Industry analysis suggests "an Anduril IPO could come in 2026 or 2027 if the Ohio manufacturing facility goes as planned and IPO conditions look relatively strong." Palmer Luckey has confirmed Anduril is "definitely going to be a publicly traded company" and running operations "to be the shape of a publicly traded company." However, the 45-cent surge to 63¢ comes despite recent skepticism. Earlier this month, prediction markets showed Anduril IPO probability plunge from 46% to 19% over seven days as investors questioned the company's $60B valuation—nearly double its previous mark despite limited revenue growth. The current rally suggests traders see momentum building toward the company's massive Ohio manufacturing facility timeline.